Følg
Roberta Zappasodi
Roberta Zappasodi
Assistant Professor of Medicine, Weill Cornell Medicine
Verificeret mail på med.cornell.edu
Titel
Citeret af
Citeret af
År
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ...
Science 348 (6230), 124-128, 2015
79752015
B cells and tertiary lymphoid structures promote immunotherapy response
BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ...
Nature 577 (7791), 549-555, 2020
16312020
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
9792017
Emerging concepts for immune checkpoint blockade-based combination therapies
R Zappasodi, T Merghoub, JD Wolchok
Cancer cell 33 (4), 581-598, 2018
5162018
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
H Wang, F Franco, YC Tsui, X Xie, MP Trefny, R Zappasodi, SR Mohmood, ...
Nature immunology 21 (3), 298-308, 2020
3792020
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
S Xu, O Chaudhary, P Rodríguez-Morales, X Sun, D Chen, R Zappasodi, ...
Immunity 54 (7), 1561-1577. e7, 2021
2742021
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
LF Campesato, S Budhu, J Tchaicha, CH Weng, M Gigoux, IJ Cohen, ...
Nature communications 11 (1), 4011, 2020
2272020
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
R Zappasodi, I Serganova, IJ Cohen, M Maeda, M Shindo, ...
Nature 591 (7851), 652-658, 2021
2182021
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
AC Huang, R Zappasodi
Nature immunology 23 (5), 660-670, 2022
2132022
Rational design of anti-GITR-based combination immunotherapy
R Zappasodi, C Sirard, Y Li, S Budhu, M Abu-Akeel, C Liu, X Yang, ...
Nature medicine 25 (5), 759-766, 2019
2072019
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a …
M Di Nicola, R Zappasodi, C Carlo-Stella, R Mortarini, SM Pupa, M Magni, ...
Blood, The Journal of the American Society of Hematology 113 (1), 18-27, 2009
1532009
Non-conventional inhibitory CD4+ Foxp3− PD-1hi T cells as a biomarker of immune checkpoint blockade activity
R Zappasodi, S Budhu, MD Hellmann, MA Postow, Y Senbabaoglu, ...
Cancer cell 33 (6), 1017-1032. e7, 2018
1492018
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
R Zappasodi, SM Pupa, GC Ghedini, I Bongarzone, M Magni, AD Cabras, ...
Cancer research 70 (22), 9062-9072, 2010
1492010
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
HM Kluger, HA Tawbi, ML Ascierto, M Bowden, MK Callahan, E Cha, ...
Journal for immunotherapy of cancer 8 (1), 2020
1442020
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human …
R Zappasodi, M Di Nicola, C Carlo-Stella, R Mortarini, A Molla, C Vegetti, ...
haematologica 93 (10), 1523-1534, 2008
842008
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab
L Castagnoli, M Iezzi, GC Ghedini, V Ciravolo, G Marzano, A Lamolinara, ...
Cancer research 74 (21), 6248-6259, 2014
812014
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
D Bedognetti, M Ceccarelli, L Galluzzi, R Lu, K Palucka, J Samayoa, ...
Journal for immunotherapy of cancer 7, 1-23, 2019
772019
The new era of cancer immunotherapy: manipulating T-cell activity to overcome malignancy
DN Khalil, S Budhu, B Gasmi, R Zappasodi, D Hirschhorn-Cymerman, ...
Advances in cancer research 128, 1-68, 2015
622015
Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma
A Anichini, A Molla, C Vegetti, I Bersani, R Zappasodi, F Arienti, ...
Cancer research 70 (21), 8378-8387, 2010
542010
Lymphoma immunotherapy: current status
R Zappasodi, F De Braud, M Di Nicola
Frontiers in Immunology 6, 163003, 2015
512015
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20